Jane Edwards
Battelle has received a potential five-year, $59 million contract from the U.S. Army to conduct research and develop therapeutics and vaccines for chemical and biological threats.
The Army’s joint program executive office for chemical and biological defense awarded the contract through the General Services Administration‘s One Acquisition Solution for Integrated Services contract vehicle, Battelle said Monday.
Battelle will work to develop vaccines for filovirus, botulinum, plague, equine encephalitis and other viruses that could be potentially used as biological weapons.
Contract work also covers the development of medical countermeasures against poisonous toxins and nerve agents used in chemical warfare.
